News Image

Tevogen Shares Valuation of Key Assets and Potential Forecast For Pipeline Product Focused on EBV Associated Leukemia and Lymphomas

Provided By GlobeNewswire

Last update: Sep 4, 2025

WARREN, N.J., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today shared asset value and potential forecast for the Company’s pipeline product, TVGN 930, for treatment of non-solid tumor malignancies stemming from Epstein-Barr Virus (EBV).

Read more at globenewswire.com

TEVOGEN BIO HOLDINGS INC

NASDAQ:TVGN (9/23/2025, 11:02:23 AM)

0.8384

+0 (+0.36%)


SEMPER PARATUS ACQU -CW26

NASDAQ:TVGNW (9/23/2025, 10:40:47 AM)

0.0528

0 (-8.17%)



Find more stocks in the Stock Screener

Follow ChartMill for more